Aims: To determine the morphological and immunohistochemical profile of retiform Sertoli-Leydig cell tumours and to compare the observed profile with that of adult rete ovarii. Methods and results: Nineteen retiform Sertoli-Leydig cell tumours were studied, eight by immunohistochemistry, and five examples of rete ovarii from adult females were also evaluated immunohistochemically. The patients ranged in age from 3 to 74 years with a mean age of 31 years. Four patients were virilized and had an abdominal mass; two were virilized with amenorrhoea and two had amenorrhoea alone. Eight presented with an abdominal mass and one patient was pregnant. Two tumours were incidental findings. Information on stage was available in 16 patients: 14 tumours were stage 1, one was stage 2, and one was stage 3. Fifteen tumours were of intermediate differentiation and four were poorly differentiated. Papillary structures were evident grossly in four cases. Microscopically, all cases had a retiform pattern in addition to varying quantities of sex cord, gonadal stromal and heterologous elements.
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Heterologous elements were present in 13 cases and consisted of hepatocytes (n ¼ 7), mucinous epithelium (n ¼ 7) and skeletal muscle (n ¼ 2). Immunohistochemical evaluation of eight tumours showed a more intense positivity for keratin in the retiform areas, whereas the gonadal stromal component had a more intense expression of inhibin. Inhibin stains Leydig cells strongly and hepatocytes moderately. Rete ovarii epithelium was positive for keratin and vimentin in the five cases studied, and for inhibin in one case. Follow-up was available on 13 patients. Three tumours behaved in a malignant fashion: one each was stage 1, 2, and 3 at diagnosis. Conclusions: Immunohistochemistry is useful in distinguishing retiform Sertoli-Leydig cell tumours from other tumours that they may resemble. Inclusion of
Introduction
Sertoli-Leydig cell tumours comprise an uncommon and heterogeneous group of ovarian neoplasms within the sex cord-stromal category. 1 Of the subtypes, the retiform variant of Sertoli-Leydig cell tumour is characterized by the presence of irregular anastomosing channels lined by cuboidal or columnar cells, in a background of a more common Sertoli-Leydig cell tumour. The retiform pattern is found only in intermediate and poorly differentiated Sertoli-Leydig cell tumours. The clinical profile of this rare variant includes presentation at a younger age and a lower incidence of virilization compared with other SertoliLeydig cell tumours. 2 Immunohistochemical features of retiform Sertoli-Leydig cell tumours have either been published rarely as case reports 3, 4 or included in series that have examined the immunohistochemical profiles of various groups of ovarian tumours. [5] [6] [7] This paper reports 19 cases of retiform Sertoli-Leydig cell tumour and examines the immunohistochemical findings in this variant.
Materials and methods
The files of the Armed Forces Institute of Pathology (AFIP) and the consultation files of one of the authors (F.F.N.) were searched for tumours coded as retiform Sertoli-Leydig cell tumour, Sertoli-Leydig cell tumour with retiform areas, or sex cord-stromal tumour with retiform areas. Nineteen cases were obtained for the years 1985-2000 (six AFIP, 13 F.F.N.). The original diagnostic H&E-stained slides were reviewed. Criteria for inclusion as retiform Sertoli-Leydig cell tumours 8 were a primary ovarian neoplasm where >5% of the tissue area on the slides was composed of a retiform pattern. Retiform areas were defined as irregular anastomosing slit-like spaces lined by cuboidal cells. The clinical history was obtained from the referral letter in each case. Retiform Sertoli-Leydig cell tumours were graded according to WHO guidelines. 8 The presence of sex cord-like, retiform and tubulopapillary, and gonadal stromal patterns, and any heterologous elements was recorded and scored semiquantitatively. Heterologous elements were specified as mucinous epithelium, hepatocytes, muscle, or cartilage. Hepatocytic differentiation was recognized by a combination of morphological and immunohistochemical features, and has been the subject of a separate report. 9 The presence or absence of Leydig cells, distinguished from hepatocytes on the basis of both morphology and immunohistochemical profile, was documented.
immunohistochemistry
The antibodies, suppliers, and dilutions used are shown in Table 1 . The method used was the avidin-biotinperoxidase complex. 10 Negative controls were performed by substitution of either rabbit or mouse serum for the primary antibody. In addition to the eight Areas resembling sex cords were absent or minimal in eight cases, scanty in seven cases, and comprised over 10% of tissue in four cases. They varied in appearance from well-demarcated, open tubular structures Gonadal stroma was identified in most tumours. Variably sized cellular nodules composed of blastematous-type stroma were frequently separated by hypocellular areas (Figure 3) . The cellular areas occasionally showed a poorly developed fascicular pattern, and surrounded and merged with closed Sertoli tubules. Absolute distinction between these populations was not always possible. The cellular gonadal stroma was composed of small cells that had a round-to-oval nucleus and even chromatin. Apoptotic and mitotic figures were common in these areas. Other areas of stroma more closely resembled the stroma of the mature ovarian cortex and in contrast to the blastematous stroma, contained background collagen; cells in these areas resembled fibroblasts, with oval-to-spindle nuclei with tapered ends and frequent nuclear grooves. While mitotic figures were commonly seen, apoptotic figures were less common in this population. Cellular blastematous-type gonadal stroma was commonly condensed around areas of mucinous epithelium where this heterologous element was present.
Areas of heterologous tissue were seen in 13 cases; in five, they were relatively scanty, but this may have been a function of sampling, at least for the four cases that contained mucinous epithelium. The heterologous mucinous epithelium was of intestinal type, and ranged from occasional tubules to large cysts, each lined by columnar mucinous epithelium. The relationship of these areas to the gonadal stroma varied. Some larger cysts were not in immediate proximity to stroma, others abutted on stroma, and yet other areas showed an intimate admixture of primitive gonadal stroma and small tubules lined by mucinous epithelium. Hepatocytic differentiation was seen in seven cases and has been the subject of a separate paper. 9 Hepatocytes were distinguished from Leydig cells by their morphological features and by their immunohistochemical profile. They were present as individual cells, clusters, or cords and in areas were seen to merge with the mucinous epithelium. Two cases contained skeletal muscle fibres. In one, well-formed striated muscle fibres arose from a variably cellular primitive gonadal stroma and were adjacent to foci of hepatocytic differentiation. This patient had sarcomatous tissue admixed with hepatocytic elements in the metastasis. The second case showed a densely cellular neoplasm with a fascicular pattern, most closely resembling fibrosarcoma, in which occasional neoplastic cells had cross-striations.
Leydig cells were seen in nine cases. They were variable in number and usually located in the hypocellular stroma at the periphery of a cellular stromal nodule, but were also seen intimately admixed with the retiform and mesenchymal elements. They invariably had minimal nuclear pleomorphism, and lacked mitotic activity.
A panel of immunostains that overlapped with our own has been reported on one of these cases previously. 5 Immunoreaction for keratins was variable and more intense in retiform areas ( Figure 5 ) compared with either the sex cord or stromal areas. Conversely, immunoreaction for inhibin was more intense in the sex cord and stromal areas compared with the retiform areas ( Figure 6 ). Reactivity for vimentin was stronger in stromal than in retiform areas. In retiform areas, vimentin demonstrated a restricted cytoplasmic distribution, with a predominant peri or subnuclear staining pattern. Epithelial membrane antigen (EMA) was strongly positive in the retiform areas in one case and remained so on repeat staining. Hepatocytic differentiation was confirmed by a characteristic profilevimentin-negative, but Cam 5.2, keratin cocktail, AFP, ferritin and inhibin-positive. Intestinal-type mucinous elements were present in four cases and were positive for keratin cocktail and for CK7, CK20, and chromogranin (focally) in all four. Immunoperoxidase reaction for Ki67 was performed in six cases and positivity ranged from 10% to 50%. Antibody to CD99 was negative in all five cases. Hyaline globules were negative for AFP. The results of selected immunohistochemical stains performed on eight tumours are given in Table 2 . The epithelium of the rete ovarii was positive for keratin and vimentin. The latter showed a restricted cytoplasmic distribution, frequently subnuclear, similar to the pattern seen in retiform areas of retiform Sertoli-Leydig cell tumours. Inhibin was negative in four cases, but a focally strong positive reaction was observed in one additional case.
Discussion
The clinical data in this paper differ only slightly from the largest series to date on retiform Sertoli-Leydig cell tumours.
2 Three (23%) of 13 of patients in our series for whom follow-up was available were known to have had recurrent or fatal disease, similar to the 24% in the previous series. 2 The majority of tumours (14 ⁄ 16 for which stage was recorded) were stage 1, and while the two patients with stage 2 and the stage 3 disease did poorly, one fatality (case 4) occurred secondary to a stage 1 tumour that had only mucinous epithelium as a heterologous element, comprising <10% of the tumour. We did not examine chemotherapeutic or other treatment regimes used in this patient cohort. While most patients with retiform Sertoli-Leydig cell tumours will be cured of disease, we believe caution regarding prognosis is warranted, even in stage 1 tumours that lack known poor prognostic variables such as mesenchymal heterologous elements.
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Due to their rarity and the considerable variation in their morphology, Sertoli-Leydig cell tumours may be mistaken for a variety of neoplasms. In contrast to other ovarian neoplasms, there is little experience with the immunohistochemical profile of retiform SertoliLeydig cell tumours; the scant available information is based on one or two such tumours reported as part of a larger group of Sertoli-Leydig cell tumours. [5] [6] [7] Immunohistochemistry for inhibin has been found particularly useful in the separation of the broad category of sex cord-stromal tumours of the ovary from their histological mimics. [12] [13] [14] [15] The major series on 25 retiform Sertoli-Leydig cell tumours 2 was written before the widespread use of immunohistochemistry. Two of four retiform Sertoli-Leydig cell tumours were noted to show Ôonly minor focal stainingÕ in a recent study. 7 Familiarity with the immunoprofile, as outlined here, may be helpful in separating retiform Sertoli-Leydig cell tumours from other ovarian neoplasms.
The consistent positivity for inhibin in all the component tissues of these tumours, as shown in this study, is valuable in recognizing retiform Sertoli-Leydig cell tumours. A variation in the intensity of inhibin staining will be seen. Leydig cells were present in nine of 19 cases in this study. They are found in 44-98% of Sertoli-Leydig cell tumours and immunohistochemical and molecular analysis suggests they are reactive rather than neoplastic. 16 Leydig cells are typically strongly positive for inhibin and luteinized stromal cells are slightly less so. The reaction for inhibin was generally of weak to moderate intensity in retiform areas and of moderate intensity in sex cord areas. Cells that resemble Leydig cells, but show only weak or moderate staining for inhibin, may be hepatocytes, and this pattern of inhibin staining should prompt consideration of a broader panel of antibodies. Using keratin cocktail, vimentin, Cam 5.2 and AFP, we demonstrated hepatocytes as a heterologous element in 5 ⁄ 8 cases and believe that it is a more common finding than the literature suggests. 9 We noted a difference between the intensity of reaction for inhibin between retiform areas, and sex cord or stromal areas, the latter being more intense. This may be of diagnostic significance in the occasional tumour that is almost exclusively retiform, or where the tissue selected for immunohistochemistry has only this pattern. We also saw focal but definite moderate (2+) positivity for inhibin in the mucinous heterologous epithelium in one case.
Specific tumours that may be considered in the differential diagnosis of retiform Sertoli-Leydig cell Retiform Sertoli-Leydig cell tumours 115 tumours include papillary serous tumours and yolk sac tumours. Papillary serous neoplasms are common, and are a likely first diagnosis. We noted a papillary component grossly in four cases of retiform SertoliLeydig cell tumour, and a papillary and tubular pattern may also dominate the microscopic picture. Demonstration of inhibin positivity in papillary and tubular structures will help make this distinction: however, as reactive ovarian stroma near any expanding neoplasm may show inhibin positivity, it should be demonstrated in elements additional to stroma. Retiform SertoliLeydig cell tumours may be mistaken for endodermal sinus tumours. 17 Yolk sac tumours or endodermal sinus tumours also occur in young females, and typically have a raised serum AFP. Raised serum AFP may also be found in patients with Sertoli-Leydig cell tumours, 18 increasing the suspicion of endodermal sinus tumour, although levels in Sertoli-Leydig cell tumours are usually low. The gross appearance of Sertoli-Leydig cell tumours and endodermal sinus tumours may overlap, both being large, unilateral neoplasms with haemorrhage and necrosis. The papillary pattern that may be seen microscopically in endodermal sinus tumours also overlaps with the retiform pattern of Sertoli-Leydig cell tumours. Immunohistochemical demonstration of AFP in endodermal sinus tumours can aid in their correct diagnosis-endodermal sinus tumours will show more extensive positivity in contrast with the localization of immunoreaction to small foci of hepatocytes in SertoliLeydig cell tumours.
Other neoplasms that may be considered in the differential include undifferentiated carcinoma, carcinoid tumour, struma ovarii or endometrial stromal sarcoma, 12 sertoliform endometrioid carcinoma, 19 or carcinosarcoma. 5 Inhibin should be included with a panel of antibodies to enable diagnosis of Sertoli-Leydig cell tumour.
Vimentin was present in all components of the tumour (except certain heterologous elements such as liver and mucinous epithelium) and appeared less intense in the retiform areas compared with the stromal areas. Keratin, in contrast, was stronger in retiform areas. The sex cord structures were immunoreactive with both vimentin and keratin. Similar to the case reported by Hittmair et al., 3 we found that the more solid tubules showed maximal staining for vimentin, with less extensive (although still intense) subnuclear vimentin expression in open tubules. CD99 is a transmembrane glycoprotein encoded by the MIC-2 gene, and has been identified immunohistochemically in Sertoli-Leydig cell tumours 20 and other tumours. 21 The staining in Sertoli-Leydig cell tumours has been described as focal and predominantly in Sertoli cells. 20 We were unable to demonstrate staining in any of the six cases evaluated. EMA was positive in one case, and remained positive on repeat staining. This was seen in the retiform areas of the tumour, which otherwise displayed a typical immunoprofile as outlined here. Rarely, EMA positivity has been reported in SertoliLeydig cell tumours. 15, 22 Expression of oestrogen and progesterone receptors (ER ⁄ PR) was of moderate degree in sex cords, while intense expression of PR was noted in the retiform areas. In a recent case where ER ⁄ PR were evaluated in a recurrence of a SertoliLeydig cell tumour during pregnancy, both were found to be negative. 23 A retiform pattern may also be seen in the female adnexal tumour of probable Wolffian origin (FATWO), or Wolffian adnexal tumour. 24 These rare tumours are also positive for keratins, inhibin and vimentin, with variable ER ⁄ PR positivity. A description of an adnexal or occasionally ovarian hilar location assists in identifying these neoplasms. The identification of heterologous elements in a tumour implies a diagnosis of Sertoli-Leydig cell tumour rather than FATWO. FATWO may contain well-formed tubules with lumens, resembling Sertoli tubules. However, the solid areas of these tubules differ from the blastematous or mature gonadal stromal types of stroma seen in retiform Sertoli-Leydig cell tumours. Inhibin positivity was reported in 68% 24 and 90% 7 of FATWO, but is patchy and weak, in contrast to the strong diffuse staining that is more usually seen in Sertoli-Leydig cell tumours. The immunoprofile of FATWO suggests that they may be derived from Wolffian (mesonephric) remnants such as the rete ovarii. 24 We noted a similar pattern of keratin and vimentin distribution in epithelial cells of the rete ovarii and in retiform areas of the retiform SertoliLeydig cell tumours.
One of us (F.F.N.) has previously commented on the morphology of the rete ovarii as reflecting a structure intermediate or transitional between mesonephric tubules and sex cords. 25 The theory that the sex cords, rather than the mesonephros, gives rise to the rete ovarii has been advanced. 26 It may be that SertoliLeydig cell tumours, retiform Sertoli-Leydig cell tumours and FATWO comprise a spectrum of neoplasms whose tissue components and clinical behaviour reflect the instability of the associated mesenchyme. Retiform Sertoli-Leydig cell tumour is the neoplasm with the earliest clinical occurrence, the most aggressive behaviour, and the greatest range of tissue types. The instability of the blastema-type stroma frequently found in retiform Sertoli-Leydig cell tumours may be the reason for the extensive variety of tissue types seen in these neoplasms. Another neoplasm with mesenchymal and epithelial components in which heterologous elements are frequently found is Wilm's tumour. The WT-1 gene has important roles in the development of kidney and gonad, 27 and exploration of its role in retiform Sertoli-Leydig cell tumours may help understand the pathogenesis of heterologous elements in this tumour.
